This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
BackgroundCongenital heartdisease (CHD) is a major contributor to morbidity and infant mortality and imposes the highest burden on global healthcare costs. Articles were retrieved based on PRISMA Flow 2020 and inclusion and exclusion criteria.
The most-popular HEART SISTERS posts from 2023 were all over the map - from 'Struggle Care' to sweating, hanging up that iconic Red Dress, or cardiac arrest on the toilet!
Abstract Worldwide, valvular heartdisease (VHD) is a common cause of hospitalization for acute heart failure. In acute heart failure caused by VHD, symptoms result from rapid haemodynamic changes and subsequent decline in cardiac function, and if left untreated, leads to acute decompensation and cardiogenic shock.
Here are five things everyone should know about sleep and heartdisease. Insulin resistance is a precursor condition to metabolic syndrome and type 2 diabetes, both major drivers of heartdisease. When you have gotten all four crucial lifestyle factors wrong, you are only left with medications and procedures.
However, according to new research published in the American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, breathing through the nose leads to several benefits, including lower blood pressure and other factors that could predict heartdisease risk. The study was chosen as an APSselect article for January.
The article by Gwak et al provides a pivotal contribution to this field, illustrating that early surgical intervention for tricuspid regurgitation (TR) in patients with low to intermediate risk yields significant survival benefits. 2 3 Furthermore, persistent.
Patients with a common heart arrhythmia called Atrial Fibrillation could benefit from future treatments that target inefficiencies in heart cell metabolism, according to a new article.
A new article could spur the development of new and improved treatments for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder with no known cure that causes accelerated aging in children.
Developments in cardiovascular (CV) surgery and related care have led to the improved survival of patients with congenital heartdisease (CHD) and more teenagers and adults living with congenital heartdisease (ACHD).
Adipose-derived mesenchymal stem cells (ASCs) represent an innovative candidate to treat ischemic heartdisease (IHD) due to their abundance, renewable sources, minor invasiveness to obtain, and no ethical limitations.
In this panel discussion, host Andrea Price MS, AACC brings together Tricia Keegan, NP, DNP, FACC, Disty Pearson, PA-C, AACC, and Bailey Estes MSN, AGNP-C, to explore best practices related to structural heartdisease. In this episode, the focus is on congenital heartdisease.
addressed the safety, tolerability, and outcomes of patients with adult congenital heartdisease (ACHD) treated with sodium-glucose cotransporter 2 inhibitors (SGLT2i). Neijenhuis et al. and Fusco et al.
February marks Congenital Heart Defect Awareness Week, an opportunity to reflect on the remarkable advancements in the care for congenital heartdisease (CHD). Historically viewed with a grim outlook, CHD has journeyed from a potentially lethal condition to a chronic disease managed into adulthood.
In these panel discussions, host Andrea Price MS, AACC brings together Kim Guibone, DNP, ACNP-BC, FACC, Susan Schnell, ACNP and Bailey Estes MSN, AGNP-C, to explore best practices related to structural heartdisease.
Background While research on congenital heartdisease has been extensively conducted worldwide, comprehensive studies from developing countries and the Arab world remain scarce. Aim This study aims to perform a bibliometric review of research on congenital heartdisease in the Arab world from 1997 to 2022.
Even though there is substantial variability in the contents and nutritional profiles of plant-based meat alternatives (PBMAs), the nutritional profiles tend to reflect a heart-healthy dietary pattern.
The majority of readers here are middle-aged and concerned about their future risk of heartdisease. Most either had a risk factor they were worried about or a family history of heartdisease that concerned them. There are loads of great resources available to explain what heartdisease is and why it happens.
Cardiac device therapy is frequently required for individuals with adult congenital heartdisease (ACHD), whether it be for bradyarrhythmia, ventricular tachyarrhythmia, or cardiac resynchronization therapy (CRT).
Introduction Carcinoid heartdisease (CHD), a complication of carcinoid syndrome (CS), is a rare condition that can lead to right sided valvular heartdisease and has been traditionally associated with a poor prognosis. Results A total of 36 articles were included in the systematic review analysis.
We have read the article by Chung W et al (1) with great interest. Although considered safe in healthy individuals (2), the vagal attenuation effect has not been specifically evaluated in heartdisease patients yet, and its impact on this particular population is therefore, unknown.
Cardiovascular diseases (CVDs) are the leading global cause of mortality, with South America reflecting similar trends. Among congenital heartdiseases (CHDs), atrioventricular (AV) block is included. This article describes the case report of a young Ecuadorian child diagnosed with AV block and bradycardia.
The prevalence of congenital heartdisease (CHD) is higher among those who live at higher altitudes, and more prevalent among females, according to a new study presented at ACC Latin America 2024.
What is the feasibility and safety of ventricular tachycardia (VT) ablation in patients with structural heartdisease using a zero-fluoroscopy approach?
Significant complications associated with this condition include ischemic stroke, heart failure, myocardial infarction, chronic kidney disease, dementia and mortality. In a new review article scientists summarize the current evidence regarding the epidemiology, pathophysiology, diagnosis and management of AF.
Sometimes, it takes just two hours to properly understand how to assess your risk of heartdisease and how to use a lifestyle-first approach to reducing heartdisease. But with over 100 articles, it can be hard to piece it all together though. That is why I created the Heart Health Formula EXPRESS.
The prevalence of congenital heartdisease (CHD) in pregnancy increased by >30% during the 2010s. CHD is now present in approximately 8:10,000 pregnant persons.
Cavalcante will discuss Valvular HeartDisease: Multimodality imaging evaluation, the future of advanced imaging, future imaging markers in development for patients with valvular heartdisease. In this episode, Drs. Purvi Parwani and João L.
The following are key points to remember from an American Heart Association Scientific Statement on neurodevelopmental outcomes for individuals with congenital heartdisease, which includes updates in neuroprotection, risk-stratification, evaluation, and management.
What is the impact of intraoperative His bundle (HB) mapping during complex biventricular congenital heartdisease (CHD) repair on postoperative atrioventricular block requiring pacemaker (AVB/PM)?
He doesn't read every article but reads most of them. When we were out for dinner, he asked me for the main things he needed to know about preventing heartdisease. What causes heartdisease? Which is why I created the Heart Health Formula EXPRESS. They are answered in the Heart Health Formula EXPRESS.
Blood Pressure Many medications used to treat congenital heartdisease can affect blood pressure levels. Electrolyte levels Certain medications used to treat congenital heartdisease can affect the levels of electrolytes in your body, such as potassium, sodium, and magnesium.
The following are key points to remember from an American Heart Association scientific statement on the evaluation and management of chronic heart failure (HF) in children and adolescents with congenital heartdisease (CHD).
In recent years, artificial intelligence (AI) has been used to improve the precision of valvular heartdisease diagnosis and treatment. This review article explores the various potential applications of AI in the diagnosis and treatment of valvular heartdisease in more detail.
Congenital heartdisease is a daunting diagnosis for any parent. We’ll cover common types of medications used to treat congenital heartdisease, what parents should know about their use, and potential side effects to watch out for. Be sure to talk to your doctor if you have any questions or concerns.
Rheumatic heartdisease mortality in Indigenous and non-Indigenous Australians between 2010 and 2017. Heart 2023; 109 :1025-1033. This article has been corrected since it was first published. Stacey I, Seth R, Nedkoff L, et al.
The goal of the VANISH2 trial was to compare endocardial catheter ablation with conventional antiarrhythmic drug (AAD) therapy as a first-line treatment for infarct-related ventricular tachycardia (VT) in ischemic cardiomyopathy.
The following are key points to remember from a 2024 report of the American College of Cardiology/American Heart Association (ACC/AHA) on performance and quality measures for adults with valvular and structural heartdisease.
William Boden and Bradley Maron discuss the latest advancements in managing pulmonary hypertension caused by left heartdisease. In this interview, Drs.
Total anomalous pulmonary venous connection (TAPVC) is a rare congenital heartdisease characterized by the inability of all pulmonary veins to connect to the left atrium. Our previous bibliometric article sum.
In fact the Circulation article cited is on Complete Transposition of the Great Vessels. All these features together in a cyanotic congenital heartdisease is characteristic of tricuspid atresia. The sign has been described in VSD with biventricular hypertrophy in children.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content